Goal of this study

To treat Alzheimer’s disease.


Alzheimer’s disease is a brain disease that gradually destroys memory and thinking skills. This study will examine the efficacy of a technique named repetitive Transcranial Magnetic Stimulation (rTMS) as a treatment for Alzheimer’s disease in patients diagnosed with early or moderate Alzheimer’s disease. Repetitive Transcranial Magnetic Stimulation consists of applying magnetic pulses through the skull to activate neurons. Treatments will be administered daily (5 days/week) for either 2 weeks or 4 weeks.

Who can participate in this study?

Patients who have been diagnosed with mild cognitive impairment due to Alzheimer’s disease or with mild or moderate Alzheimer’s disease may be eligible to participate in this study. This study accepts both men and women and does not accept healthy volunteers.

Important: Additional eligibility criteria apply and the patient’s record will be verified by the study doctor (with the patient’s approval) to confirm eligibility.

Clinicaltrials.gov identifier: NCT02908815

Contact Information

To know if you're eligible to participate in this trial, please fill-up the form below and we will contact you shortly.